Perspective Therapeutics (CATX) Return on Sales (2010 - 2023)

Perspective Therapeutics (CATX) has 14 years of Return on Sales data on file, last reported at 0.01% in Q4 2023.

• For the quarter ending Q4 2023, Return on Sales changed N/A year-over-year to 0.01%; the trailing twelve-month figure through Dec 2023 stood at 0.11% (changed N/A YoY), and the FY2023 full-year result was 0.06%, changed N/A from the prior year.
• Return on Sales grew to 0.01% in Q4 2023, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2023 to a low of 0.01% in Q1 2021.
• A 5-year average of 0.01% and a median of 0.01% in 2019 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales grew 1 bps in 2019 and fell 1 bps in 2021, its largest moves.
• Tracing CATX's Return on Sales over 5 years: stood at 0.01% in 2019, then advanced by 19 bps to 0.0% in 2020, then decreased by 19 bps to 0.01% in 2021, then sank by 84 bps to 0.01% in 2022, then surged by 201 bps to 0.01% in 2023.
• Business Quant data shows CATX's Return on Sales at 0.01% in Q4 2023, 0.0% in Q3 2023, and 0.01% in Q2 2023.